Home › Products › Oncology › Tauritmo 25mg Capsule
Tauritmo 25mg Capsule
Salt Composition: MIDOSTAURIN
- Manufacturer: NOVARTIS INDIA LTD
- Pack Size: 4 CAPSULE(s) IN A STRIP
- Dosage Form: CAPSULE
- Strength: 25MG
- Prescription Required
- Storage: Store Tauritmo 25mg capsule at room temperature (25°C) keep the capsule away from the reach of children and pets. If you miss a dosage, take it as soon as you remember. If it is almost time for the next dose, skip the missing dose. Do not take a double dose to compensate for a missed dose.
₹3249.00₹3314.73
Inclusive of all taxes
Product Introduction
Tauritmo 25mg capsule contains midostaurin, an anti-cancer medicine belonging to the class of tyrosine kinase inhibitors. It is used in combination with other chemotherapy medications to treat acute myeloid leukaemia (AML) in adults with a defect in the FLT3 gene. Acute myeloid leukaemia is a form of cancer arising in myeloid cells, a type of white blood cell, in which the body abnormally overproduces these cells. The medicine is also used in adults to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL).
Do not take Tauritmo 25mg capsule if you are allergic to midostaurin or any other ingredient in this medicine. Inform your healthcare professional if you have any symptoms of infection, heart disorder, lung problems, or breathing difficulties. If you experience symptoms such as fever, sore throat, mouth ulcers, cough with or without mucous, chest pain, difficulty breathing, or swelling in body parts after taking the medicine, report this immediately to your doctor. This medicine is not recommended for children and adolescents below 18 years of age.
Inform your physician if you are pregnant, breastfeeding, or planning pregnancy before starting therapy. Tauritmo 25mg capsule may reduce fertility in men and women; discuss this with your doctor before beginning treatment. The most common side effects of this medicine are fever with reduced blood cell counts, nausea, vomiting, headache, musculoskeletal pain, increased blood glucose levels, and respiratory tract infection.
Uses
Acute myeloid leukemia (AML) Aggressive systemic mastocytosis (ASM) Systemic mastocytosis with associated hematological neoplasm (SM-AHN) Mast cell leukemia (MCL)
How it works
Tauritmo 25mg capsule is a kinase inhibitor that potently inhibits multiple receptor tyrosine kinases. It blocks the action of the kinases in the abnormal cells that express FLT3 mutant genes and stops their division and growth.
How to Use
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the Tauritmo 25mg capsule as prescribed by your doctor. Do not open, break, crush, or chew the capsules. Swallow the capsule whole with a glass of water. Take the capsules with food at the same time each day.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Swelling in the lower limbs Skin rash Increased blood sugar levels Abdominal pain Constipation, diarrhea Nausea, vomiting Musculoskeletal pain Headache Bleeding from nose Upper respiratory infection Tiredness Fever Serious Heart failure GI bleeding Fever with decreased blood cell counts Hypersensitivity reactions Kidney problems Pneumonia Blood infection
Expert Tips
Do not breastfeed during the treatment with Tauritmo 25mg capsule and for at least 4 months after the last dose. Avoid grapefruit juice during the treatment with this medicine. If you vomit after taking this medicine, do not take another capsule to make up the dose. If you are a male patient with a female partner with reproducing potential, use effective contraception during the treatment and for 4 months after the last dose. Your doctor will perform regular blood tests during the treatment to monitor the number of blood cells and electrolytes in your body. Your heart and lung function will also be checked regularly. This medicine may make you bleed, bruise, or get infections more easily. Take precautions to prevent illness and injury.
References
- Novartis Pharmaceuticals, Electronic Medicines Compendium (EMC), www.medicines.org.uk. [revised on 2022] [cited 2023 Apr 13]. Available from: https://www.medicines.org.uk/emc/product/9134/smpc
- Novartis Pharmaceuticals, Highlights Of Prescribing Information, Midostaurin, [revised on 2017] [cited 2023 Apr 13]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207997s000lbl.pdf
- Anton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules, Goodman & Gilmanâs Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1203-1236.
Safety Advice
Pregnancy: unsafe Tauritmo 25mg capsule is unsafe to administer in pregnant women because it may cause birth defects. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using effective contraception during the treatment and for at least 4 months after your last dose is necessary.
Lungs: Consult your doctor It is unknown whether Tauritmo 25mg capsule can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Tauritmo 25mg capsule because the medicine passes into the breast milk in small amounts and may harm the baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.